Altimmune, Inc. Common Stock

ALTNASDAQ • USD
1.60 USD
↘ 0.05 (3.04%)🟢LIVE (AS OF 11:25 AM EST)
🟢Market: OPEN

Shares of Altimmune, Inc. Common Stock (ALT) are trading at $1.60. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place ALT at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$1.64
High?$1.79
Low?$1.51
Prev. Close?$1.65
Volume?2.3M
Avg. Volume?3.9M
VWAP?$1.58
Rel. Volume?0.59x
Bid / Ask
Bid?$1.58 × 25.5K
Ask?$1.59 × 3.7K
Spread?$0.01
Midpoint?$1.59
Valuation & Ratios
Market Cap?321.1M
Shares Out?194.5M
Float?190.6M
Float %?98.0%
P/E Ratio?N/A
P/B Ratio?0.72
EPS?-$0.54
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
Employees
57
Market Cap
320.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2005-10-06
Address
350 MOUNT KEMBLE AVENUE
MORRISTOWN, NJ 07960
Phone: 862-457-1450
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
21
Momentum?
50
Short Sent.?
19
Piotroski F-Score?0/9Weak
Altman Z-Score?1.52Distress
Confidence?60%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?22.11%Squeeze Risk
Short Interest?42.1M
Days to Cover?12.2
Free Float190.6M
Avg Daily Volume3.5M
Settlement Date2026-10-30
Financial Health
Current Ratio?23.93Strong
Quick Ratio?23.93Strong
Cash Ratio?2.51Strong
Debt/Equity?0.08Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.72CHEAP▾
P/S?
Peers
100
S&P
3
12,348.95HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.9CHEAP▾
EV/Sales?
Peers
100
S&P
3
12,583.60HIGH▾
Returns & Efficiency
ROE?
S&P
7
-23.6%WEAK▾
ROA?
S&P
3
-21.1%WEAK▾
Cash Flow & Enterprise
FCF?$-102473000
Enterprise Value?$327.2M
Fundamentals ratios updated end of day